INDEPENDENT OBSERVATORY

What's being reported?

A searchable, contextualised database of adverse-event signals for drugs, devices, supplements and cosmetics. Quantitative, compared, in plain language.

Popular: tirzepatide · semaglutide · somatropin

20.3M

FAERS reports

25M

MAUDE device reports

260K

drug labels linked

public FDA sources

WHAT STANDS OUT NOW

Signals worth watching.

140,435 reports · 17.1% serious

Report volume · last 8 quarters

Top signal140,435

semaglutide

Drug

Ozempic · Wegovy · Rybelsus

82,911 reports · 53.7% serious

Report volume · last 8 quarters

Top signal82,911

somatropin

Drug

Genotropin · Humatrope · Norditropin

71,462 reports · 26.0% serious

Report volume · last 8 quarters

Top signal71,462

FOUR PUBLIC SOURCES

Everything that gets reported — not one niche.

From painkillers to weight-loss injections, from hip implants to vitamin pills. We cover every field the FDA databases track.

Hair & GLP-1

Source: FAERS

4 entries → · 326,383 reports

Injectables

Source: FAERS + MAUDE

2 entries → · 36,951 reports

Hormones

Source: FAERS

1 entries → · 71,462 reports

Longevity & supplements

Source: CAERS

3 entries → · 4,513 reports

RECENT RECALLS

All recalls →

Jul 30glutathione — Lack of Assurance of Sterility Jul 30copper peptide — Lack of Assurance of Sterility Jul 30glutathione — Lack of Assurance of Sterility

TRENDING SYMPTOMS

All symptoms →

Incorrect Dose Administered3 substances →Nausea3 substances →Drug Dose Omission By Device1 substances →Injection Site Pain2 substances →Vomiting4 substances →

OUR APPROACH

From raw report to meaning.

Data

We pull raw reports from the public FDA databases: FAERS, MAUDE, CAERS and cosmetic events.

Signal calculation

For each symptom we compute the reporting odds ratio with a confidence interval — how much it stands out versus all other products.

Interpretation

We compare against the label and write a short plain-language explanation. A signal is not a cause.

Read the full method →